US4610879A
(en)
|
1984-01-06 |
1986-09-09 |
University Of Southern California |
Fibrinolytic enzyme from snake vernom
|
US5066592A
(en)
|
1988-03-08 |
1991-11-19 |
Temple University Of The Commonwealth System Of Higher Education |
Trigramin - a platelet aggregation inhibiting polypeptide
|
US6133029A
(en)
|
1988-03-21 |
2000-10-17 |
Chiron Corporation |
Replication defective viral vectors for infecting human cells
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5278324A
(en)
|
1990-08-28 |
1994-01-11 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble derivatives of taxol
|
US5227400A
(en)
|
1991-09-23 |
1993-07-13 |
Florida State University |
Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
|
US5250683A
(en)
|
1991-09-23 |
1993-10-05 |
Florida State University |
Certain substituted taxanes and pharmaceutical compositions containing them
|
US5272171A
(en)
|
1992-02-13 |
1993-12-21 |
Bristol-Myers Squibb Company |
Phosphonooxy and carbonate derivatives of taxol
|
US5248796A
(en)
|
1992-06-18 |
1993-09-28 |
Bristol-Myers Squibb Company |
Taxol derivatives
|
US5254580A
(en)
|
1993-01-19 |
1993-10-19 |
Bristol-Myers Squibb Company |
7,8-cyclopropataxanes
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
US6080569A
(en)
|
1993-06-24 |
2000-06-27 |
Merck & Co., Inc. |
Adenovirus vectors generated from helper viruses and helper-dependent vectors
|
US6710030B1
(en)
*
|
1993-10-22 |
2004-03-23 |
University Of Southern California |
Contortrostain (CN) and methods for its use in preventing metastasis and other conditions
|
US5814609A
(en)
|
1993-10-22 |
1998-09-29 |
University Of Southern California |
Compositions containing a disintegrin and methods for its use in preventing metastasis and other conditions
|
US5731288A
(en)
|
1993-10-22 |
1998-03-24 |
University Of Southern California |
Compositions containing contortrostatin and methods for the use thereof
|
US20030186884A1
(en)
|
2000-06-08 |
2003-10-02 |
Markland Francis S. |
Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
|
US7220724B2
(en)
|
1993-10-22 |
2007-05-22 |
University Of Southern California |
Contortrostatin CN and methods for its use in preventing metastasis and other conditions
|
US5658785A
(en)
|
1994-06-06 |
1997-08-19 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
FR2725726B1
(fr)
|
1994-10-17 |
1997-01-03 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en therapie genique
|
US5641665A
(en)
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
US6040295A
(en)
|
1995-01-13 |
2000-03-21 |
Genemedicine, Inc. |
Formulated nucleic acid compositions and methods of administering the same for gene therapy
|
US6096534A
(en)
|
1995-05-22 |
2000-08-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells
|
AU5253998A
(en)
|
1996-11-13 |
1998-06-03 |
Board Of Regents, The University Of Texas System |
Diminishing viral gene expression by promoter replacement
|
US6380394B1
(en)
|
1996-12-13 |
2002-04-30 |
The Scripps Research Institute |
Epothilone analogs
|
US6660758B1
(en)
|
1996-12-13 |
2003-12-09 |
The Scripps Research Institute |
Epothilone analogs
|
US6441186B1
(en)
|
1996-12-13 |
2002-08-27 |
The Scripps Research Institute |
Epothilone analogs
|
US6034072A
(en)
|
1997-02-10 |
2000-03-07 |
Genemedicine, Inc. |
IL-2 gene expression and delivery systems and uses
|
DE19713213A1
(de)
|
1997-03-28 |
1998-10-01 |
Ruebben Alexander Dr Med |
Metallstent zur verlängerten Offenhaltung von Hohlorganen
|
AUPO742497A0
(en)
*
|
1997-06-18 |
1997-07-10 |
N.J. Phillips Pty. Limited |
An applicator
|
US6605599B1
(en)
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
ES2290993T3
(es)
|
1997-08-09 |
2008-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Nuevos derivados de epotilona, proceso para su produccion y su utilizacion farmaceutica.
|
US6365749B1
(en)
|
1997-12-04 |
2002-04-02 |
Bristol-Myers Squibb Company |
Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
|
US6399638B1
(en)
|
1998-04-21 |
2002-06-04 |
Bristol-Myers Squibb Company |
12,13-modified epothilone derivatives
|
US6498257B1
(en)
|
1998-04-21 |
2002-12-24 |
Bristol-Myers Squibb Company |
2,3-olefinic epothilone derivatives
|
DE19820599A1
(de)
|
1998-05-08 |
1999-11-11 |
Biotechnolog Forschung Gmbh |
Epothilonderivate, Verfahren zu deren Herstellung und deren Verwendung
|
DE19826988A1
(de)
|
1998-06-18 |
1999-12-23 |
Biotechnolog Forschung Gmbh |
Epothilon-Nebenkomponenten
|
BR9914466A
(pt)
*
|
1998-09-29 |
2001-10-16 |
Univ Southern California |
"contortrostatina (cn) e métodos para seu uso na prevenção da metástase e outras condições"
|
DE19848306A1
(de)
|
1998-10-14 |
2000-04-20 |
Schering Ag |
Verfahren zur Herstellung von Epothilon B und Derivaten sowie Zwischenprodukte für dieses Verfahren
|
US6440944B2
(en)
|
1998-10-16 |
2002-08-27 |
Genvec, Inc. |
Methods of administering adenoviral vectors
|
KR20070087132A
(ko)
|
1998-11-20 |
2007-08-27 |
코산 바이오사이언시즈, 인코포레이티드 |
에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법및 물질
|
CA2352505C
(en)
|
1998-12-22 |
2009-04-07 |
Novartis Ag |
Epothilone derivatives and their use as antitumor agents
|
US6780620B1
(en)
|
1998-12-23 |
2004-08-24 |
Bristol-Myers Squibb Company |
Microbial transformation method for the preparation of an epothilone
|
US6596875B2
(en)
|
2000-02-07 |
2003-07-22 |
James David White |
Method for synthesizing epothilones and epothilone analogs
|
HUP0105330A2
(hu)
|
1999-02-11 |
2002-05-29 |
Schering Ag. |
Epotilonszármazékok, eljárás előállításukra és gyógyszerészeti alkalmazásuk
|
IL144519A0
(en)
|
1999-02-18 |
2002-05-23 |
Schering Ag |
16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
|
US6406722B1
(en)
|
1999-02-18 |
2002-06-18 |
Robert G. Gallaher |
Method of treating viral infections and lesions with taxane compounds
|
US6387664B1
(en)
|
1999-02-26 |
2002-05-14 |
Secretary Of Agency Of Industrial Science And Technology |
Sparc fusion protein and method for producing the same
|
JP3012931B1
(ja)
*
|
1999-02-26 |
2000-02-28 |
工業技術院長 |
Sparc融合タンパク質およびその製造方法
|
AU772750C
(en)
|
1999-04-30 |
2005-02-24 |
Schering Aktiengesellschaft |
6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
|
US6878699B1
(en)
|
1999-05-21 |
2005-04-12 |
University Of Hawaii |
Taccalonolide microtubule stabilizing agents
|
US20050042275A1
(en)
|
1999-08-04 |
2005-02-24 |
Jean-Claude Sonntag |
Epothilone compositions
|
US6294374B1
(en)
|
1999-10-08 |
2001-09-25 |
The Scripps Research Institute |
Use of catalytic antibodies for synthesizing epothilone
|
AU2077001A
(en)
|
1999-12-10 |
2001-06-18 |
University Of Southern California |
Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions
|
US6518421B1
(en)
|
2000-03-20 |
2003-02-11 |
Bristol-Myers Squibb Company |
Process for the preparation of epothilone analogs
|
US6593115B2
(en)
|
2000-03-24 |
2003-07-15 |
Bristol-Myers Squibb Co. |
Preparation of epothilone intermediates
|
TWI310684B
(en)
|
2000-03-27 |
2009-06-11 |
Bristol Myers Squibb Co |
Synergistic pharmaceutical kits for treating cancer
|
DE10020517A1
(de)
|
2000-04-19 |
2001-10-25 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
US6998256B2
(en)
|
2000-04-28 |
2006-02-14 |
Kosan Biosciences, Inc. |
Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
|
US6489314B1
(en)
|
2001-04-03 |
2002-12-03 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
US20020045609A1
(en)
|
2000-05-26 |
2002-04-18 |
Gary Ashley |
Epothilone derivatives and methods for making and using the same
|
US6638742B1
(en)
|
2000-07-07 |
2003-10-28 |
University Of Portland |
Methods for obtaining taxanes
|
UA75365C2
(en)
|
2000-08-16 |
2006-04-17 |
Bristol Myers Squibb Co |
Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
|
EP1358144B1
(de)
|
2000-10-16 |
2006-12-27 |
R&D-Biopharmaceuticals |
Epothilon-synthesebausteine i: unsymmetrisch substituierte acyloine und acyloinderivate, verfahren zu deren herstellung sowie deren verwendung zur herstellung von epothilonen und epothilonderivaten
|
JP2004514433A
(ja)
|
2000-11-22 |
2004-05-20 |
ノバルティス アクチエンゲゼルシャフト |
エポチロン耐性セルライン
|
WO2002055106A2
(en)
|
2001-01-09 |
2002-07-18 |
Merck Patent Gmbh |
Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
|
PL367260A1
(en)
|
2001-01-25 |
2005-02-21 |
Bristol-Myers Squibb Company |
Parenteral formulation containing epothilone analogs
|
DK1353668T3
(da)
|
2001-01-25 |
2008-06-30 |
Bristol Myers Squibb Co |
Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer
|
US20030004338A1
(en)
|
2001-02-01 |
2003-01-02 |
Li Wen Sen |
Process for the preparation of epothilone analogs
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
WO2002066038A1
(en)
|
2001-02-20 |
2002-08-29 |
Bristol-Myers Squibb Company |
Treatment of refractory tumors using epothilone derivatives
|
HUP0400041A2
(hu)
|
2001-02-20 |
2004-04-28 |
Bristol-Myers Squibb Co. |
Epotilonszármazékok alkalmazása makacs tumorok kezelésére szolgáló gyógyszerkészítmények előállítására
|
MXPA03007729A
(es)
|
2001-02-27 |
2003-12-04 |
Novartis Ag |
Combinacion que comprende un inhibidor de transduccion de senal y un derivado de epotilona.
|
BRPI0207961B8
(pt)
|
2001-03-14 |
2021-05-25 |
Bristol Myers Squibb Co |
uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
|
MXPA03008462A
(es)
|
2001-03-19 |
2003-12-08 |
Novartis Ag |
Combinaciones que comprenden un agente antidiarreico y una epotilona o un derivado de epotilona.
|
US6906188B2
(en)
|
2001-04-30 |
2005-06-14 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method for synthesizing epothilones and epothilone analogs
|
US20030023082A1
(en)
|
2001-05-15 |
2003-01-30 |
Gary Ashley |
Epothilone derivatives and methods for making and using the same
|
WO2002098868A1
(en)
|
2001-06-01 |
2002-12-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
DE10138347A1
(de)
|
2001-08-03 |
2003-02-27 |
Schering Ag |
Geschützte 3,5-Dihydroxy-2,2-dimethyl-valeronitrile für die Synthese von Epothilonen- und Derivaten und Verfahren zur Herstellung
|
DE60229143D1
(en)
|
2001-08-23 |
2008-11-13 |
Novartis Ag |
Cyclopropyl und cyclobutyl epothilon analoge
|
US20030186334A1
(en)
|
2001-09-12 |
2003-10-02 |
Temple University - Of The Commonwealth System Of Higher Education |
KTS-disintegrins
|
WO2003029195A1
(fr)
|
2001-09-28 |
2003-04-10 |
Sumika Fine Chemicals Co., Ltd. |
Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production
|
AU2002363803A1
(en)
|
2001-11-15 |
2003-05-26 |
Kosan Biosciences, Inc. |
Method for making epothilone compounds by bioconversion with microorganisms
|
TW200408407A
(en)
|
2001-11-30 |
2004-06-01 |
Dana Farber Cancer Inst Inc |
Methods and compositions for modulating the immune system and uses thereof
|
DE10164592A1
(de)
|
2001-12-21 |
2003-07-03 |
Schering Ag |
C1-C6-Epothilon-Fragmente und Verfahren für die Herstellung von C1-C6-Fragmenten von Epothilonen und deren Derivaten
|
TW200303202A
(en)
|
2002-02-15 |
2003-09-01 |
Bristol Myers Squibb Co |
Method of preparation of 21-amino epothilone derivatives
|
WO2003074521A1
(en)
|
2002-03-01 |
2003-09-12 |
University Of Notre Dame |
Derivatives of epothilone b and d and synthesis thereof
|
DK1483251T3
(da)
|
2002-03-12 |
2010-04-12 |
Bristol Myers Squibb Co |
C3-cyano-epothilon-derivater
|
WO2003077903A1
(en)
|
2002-03-12 |
2003-09-25 |
Bristol-Myers Squibb Company |
C12-cyano epothilone derivatives
|
PL211114B1
(pl)
|
2002-05-01 |
2012-04-30 |
Novartis Ag |
Zastosowanie pochodnej epotilonowej w leczeniu choroby nowotworowej
|
TW200400191A
(en)
|
2002-05-15 |
2004-01-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives
|
AU2003296878A1
(en)
|
2002-05-20 |
2004-12-13 |
Kosan Biosciences, Inc. |
Methods to administer epothilone d
|
US7799561B2
(en)
*
|
2002-06-12 |
2010-09-21 |
Sigma-Aldrich, Co. |
Affinity peptides and method for purification of recombinant proteins
|
US7008936B2
(en)
|
2002-06-14 |
2006-03-07 |
Bristol-Myers Squibb Company |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
|
ATE381569T1
(de)
|
2002-08-02 |
2008-01-15 |
Novartis Pharma Gmbh |
Epothilonderivate
|
US7053201B2
(en)
|
2002-08-30 |
2006-05-30 |
National Defense Medical Center |
Nucleic acid molecules and polypeptides related to h-ADAM7
|
CN101050445B
(zh)
|
2002-09-23 |
2011-08-10 |
布里斯托尔-迈尔斯斯奎布公司 |
产埃坡霉素的微生物
|
GB0230024D0
(en)
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
JP2004217535A
(ja)
|
2003-01-10 |
2004-08-05 |
Nec Soft Ltd |
蛋白質trimestatinの結晶化、構造座標の決定、構造座標の使用
|
US7763430B2
(en)
*
|
2003-04-22 |
2010-07-27 |
Baxter International Inc. |
Diagnostic assay for anti-von Willebrand Factor cleaving protease (ADAMTS13) antibodies
|
CA2539975C
(en)
|
2003-09-25 |
2012-11-20 |
Tapestry Pharmaceuticals, Inc. |
9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
|
US7960513B2
(en)
|
2004-12-17 |
2011-06-14 |
Monash University |
Antibody against a human ADAM protease
|
CN101535492A
(zh)
|
2005-02-11 |
2009-09-16 |
南加州大学 |
表达含有二硫键的蛋白质的方法
|
US9265933B2
(en)
|
2005-09-08 |
2016-02-23 |
Massachusetts Eye And Ear Infirmary |
Cochlear implants containing biological cells and uses thereof
|
EP2029156A4
(en)
|
2006-05-01 |
2010-07-21 |
Univ Southern California |
POLY THERAPY FOR TREATING CANCER
|
WO2008143733A2
(en)
|
2007-03-02 |
2008-11-27 |
Dohney Eye Institute |
Biocompatible implants and methods of making and attaching the same
|
WO2010056901A2
(en)
|
2008-11-13 |
2010-05-20 |
University Of Southern California |
Method of expressing proteins with disulfide bridges with enhanced yields and activity
|
US20120142603A1
(en)
|
2009-02-12 |
2012-06-07 |
University Of Southern California |
Bioadhesive patch for sutureless closure of soft tissue
|
EP2534171A4
(en)
|
2010-02-11 |
2013-07-17 |
Univ Southern California |
MODIFIED POLYPEPTIDES OF THE DEINDEGRINE ADAM DOMAIN, AND USES THEREOF
|